Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00259155
Status:
COMPLETED
Last Update Posted:
2008-03-18
First Post:
2005-11-25
Brief Title:
Rifaximin for the Treatment of Irritable Bowel Syndrome
Sponsor:
Cedars-Sinai Medical Center
Organization:
Cedars-Sinai Medical Center
Organization Data
Organization:
Cedars-Sinai Medical Center
Class:
OTHER
Study ID:
4166
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cedars-Sinai Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bausch Health Americas Inc | INDUSTRY |
| University of Chicago | OTHER |